Company Filing History:
Years Active: 1990-1992
Title: The Innovations of Hans U Gubler
Introduction
Hans U Gubler is a notable inventor based in Koniz, Switzerland. He has made significant contributions to the field of organic compounds, particularly in the area of therapeutic applications. With a total of 2 patents to his name, Gubler's work focuses on innovative solutions for medical challenges.
Latest Patents
Gubler's latest patents include organic compounds that are designed to inhibit monokine release, specifically targeting interleukin-1. These compounds, which include .alpha.-[10-oxy-4H-benzo[4,5]cyclohepta[1,2-b]thiophen-4-ylidene]-carboxylic acids and their physiologically-hydrolysable esters or pharmaceutically acceptable salts, are useful in treating tissue calcium depletion and degenerative processes in bone. His research aims to provide therapeutic means that are alternatives to traditional anti-inflammatory or anti-pyretic treatments.
Career Highlights
Hans U Gubler is currently associated with Sandoz GmbH, a company known for its commitment to developing high-quality pharmaceuticals. His work at Sandoz has allowed him to focus on innovative research that addresses critical health issues.
Collaborations
Gubler has collaborated with notable colleagues in his field, including Pietro Bollinger and Jorg Schnyder. These collaborations have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Hans U Gubler's contributions to the field of organic compounds and therapeutic innovations highlight his role as a significant inventor. His work continues to pave the way for new treatments that can improve patient outcomes.